Loading…

ALKBH5 inhibitors as a potential treatment strategy in heart failure—inferences from gene expression profiling

Heart Failure (HF) is a complex clinical syndrome in which the heart is unable to provide enough blood flow to meet metabolic needs and lacks efficient venous return. HF is a major risk factor for morbidity and mortality with cardiovascular diseases globally. Despite enormous research, the molecular...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in cardiovascular medicine 2023-07, Vol.10, p.1194311-1194311
Main Authors: Komal, Sumra, Gohar, Atia, Althobaiti, Saad, Ahmad Khan, Ishtiaq, Cui, Liu-Gen, Zhang, Li-Rong, Han, Sheng-Na, Shakeel, Muhammad
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Heart Failure (HF) is a complex clinical syndrome in which the heart is unable to provide enough blood flow to meet metabolic needs and lacks efficient venous return. HF is a major risk factor for morbidity and mortality with cardiovascular diseases globally. Despite enormous research, the molecular markers relevant to disease prognosis and management remain not well understood. Here, we analyzed the whole transcriptomes of 18 failing hearts and 15 non-failing hearts (predominantly of Caucasian origin), by applying the standard in silico tools. The analyses revealed novel gene-markers including ALKBH5 of mRNA demethylation and KMT2E of histone modification processes, significantly over-expressed in the HF compared with the non-failing hearts (FDR 
ISSN:2297-055X
2297-055X
DOI:10.3389/fcvm.2023.1194311